Benda Pharmaceutical, Inc., a China-based company that produces Gendicine, a commercialized gene therapy drug for the treatment of cancer, received GMP certification at its newly expanded Ebei plant for its new tablets product line. The GMP certification clears the tablets for mass production and sale.     The Ebei plant is Benda’s major revenue contributor having achieved $11.8 million in revenue during the first nine months of 2007, up 55% YTD. The Ebei plant previously produced and distri...